Ampio Pharmaceuticals (AMEX: AMPE)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Ampio Pharmaceuticals (AMEX: AMPE) through any online brokerage.
There are no as such competitors for Ampio Pharmaceuticals.
The latest price target for Ampio Pharmaceuticals (AMEX: AMPE) was reported by Alliance Global Partners on Thursday, March 24, 2022. The analyst firm set a price target for 4.50 expecting AMPE to rise to within 12 months (a possible 2710.74% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Ampio Pharmaceuticals (AMEX: AMPE) is $0.1601 last updated July 1, 2022, 7:59 PM UTC.
There are no upcoming dividends for Ampio Pharmaceuticals.
Ampio Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Ampio Pharmaceuticals.
Ampio Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the AMEX.